The Texas Medical Center (TMC), which is the largest medical complex in the world, recently announced the TMC Venture Fund, a $25 million initiative designed to support new technologies and propel early-stage companies to flourish in Houston’s thriving health care ecosystem.
Texas Medical Center unveiled the exciting announcement in front of an audience of more than 600 potential investors, hospital stakeholders, advisers and members of Houston’s innovation ecosystem at the annual TMCx Demo Day on November 8, 2017, at TMC’s Innovation Institute. The TMC Venture Fund Investment Committee selected the following inaugural 2017 recipients: ALLEVIANT, BRITESEED, CNSDOSE, MEDABLE, NONINVASIX.